CClinicalTrials.gg
Not yet recruitingNCT06112457TAD-GENDGFUpdated Nov 1, 2023

Anxiety and Depression Among Gendarmes Posted to French Guiana

An observational study in Anxiety Depression Disorder, sponsored by Direction Centrale du Service de Santé des Armées. Not yet recruiting at 1 site in French Guiana. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-01.

Sponsored by Direction Centrale du Service de Santé des Armées · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
600
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This is a mixed-method, single-center study involving two concurrent phases: a quantitative phase with an anonymous self-administered questionnaires, and a qualitative phase with individual contextual interviews and a focus group. The hypothesis underlying this study is that isolated postings are a risk factor for anxiety-depressive disorders. The aim of this study is to provide new information to help propose targeted prevention and health promotion measures.

02

Conditions studied

  • Anxiety Depression Disorder
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,643 are open to participants now.

This study's planned enrollment of 600 is above the median of 160 across 1,084 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Direction Centrale du Service de Santé des Armées is the lead sponsor of 93 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

healthy volunteer

Inclusion criteria

  • Gendarme in active position
  • Age over 18
  • Assignment in French Guiana for more than 6 months at the time of the study
  • Not opting for study participation

Exclusion criteria

Exclusion Criteria:

  • Previously diagnosed psychiatric condition
  • People with a reading/writing disability in the French language
  • Major incapacity
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
600 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes

Interventions

  • OtherSurvey

    Anonymous self-administered questionnaire

06

What researchers measure

Primary outcomes

  1. Prevalence of anxiety-depressive disorders according to posting site.

    Comparison of the prevalence of anxiety-depressive disorders among gendarmes posted to French Guiana according to their posting site.

    Time frame: Through study completion (6 months)

Secondary outcomes

  1. Factors associated with the presence of an anxiety-depressive disorder

    Evaluate factors associated with the presence of an anxiety-depressive disorder, both overall and by type of disorder

    Time frame: Through study completion (6 months)

07

Study locations

1 site
  • DIASS Guyane
    Cayenne, Guyane 97306, French Guiana
    • DIA · Contact · 0594395983
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06112457
Lead sponsor
Direction Centrale du Service de Santé des Armées
Responsible party
Sponsor
First posted
Nov 1, 2023
Start date
Nov 2023 (estimated)
Primary completion
Oct 2024 (estimated)
Completion
Nov 2024 (estimated)
Last update
Nov 1, 2023

Study contacts

DIA
Contact
aissata.dia@intradef.gouv.fr
0594395983

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion